John M. Leonard
Independent Lead DirectorDr. John M. Leonard, M.D., M.P.H., is an Executive Partner at Tyree & D'Angelo Partners. He serves on the Board of Directors of IQVIA. He serves as Director at 3T Biosciences, Inc. since October 2022. He has been Independent Director at IQVIA Holdings Inc. since February 2015 and has been its Lead Independent Director since July 25, 2018. Dr. Leonard has been the President and Chief Executive Officer of Intellia Therapeutics Inc. since January 1, 2018. He served as Executive Vice President of Research & Development at Intellia since January 13, 2017 and served as its Chief Medical Officer since joining in July 2014 until January 13, 2017. Dr. Leonard had spent years at AbbVie and Abbott Laboratories from 1992, until his retirement from AbbVie in 2013. Dr. Leonard served as the Chief Scientific Officer and Senior Vice President of Pharmaceuticals, Research and Development at AbbVie Inc. since January 2013 until the end of 2013. He served as Senior Vice President of Pharmaceuticals, Research and Development at Abbott Diabetes Care, Inc. from February 2008 to 2012. Dr. Leonard served as Senior Vice President of Pharmaceuticals, Research and Development at Abbott Laboratories since February 2008. While serving as the Global Head of Pharmaceutical R&D at Abbott Laboratories, he oversaw the development of numerous novel therapeutics. His teams were twice recognized with the prestigious Prix Galien Award for excellence in pharmaceutical research. His ground-breaking work with HIV protease inhibitors Norvir and Kaletra led to new treatment paradigms for AIDS, while his years of work with Humira made it the all-time top-selling drug worldwide. Dr. Leonard served as Vice President of Global Medical & Scientific Affairs at Abbott Laboratories. He served as Vice President of Global Pharmaceutical Drug Development at Abbott Laboratories since 2001 and also Vice President of Pharmaceutical Development from 1999 to 2001, Divisional Vice President, Pharmaceutical Development, Pharmaceutical Products Research and Development from 1998 to 1999 and served as its Corporate Officer since 1999 and served as its Senior Vice President from 2008 to 2012. Since joining Abbott in 1992 as Head of the Antiviral Venture in the Pharmaceutical Products Division, Dr. Leonard has held several positions in the same division. Prior to joining Abbott, he served as Senior Director for Clinical Research at G. H. Besselaar Associates. He served as Chairman of the Supervisory Board of Abbott Germany. Dr. Leonard serves as Director of Quintiles Transnational, Inc. He has been a Director of Quintiles Transnational Holdings Inc. since February 5, 2015. He serves as a Director of Intellia Therapeutics Inc. Dr. Leonard was a Director of Chimerix Inc. until June 20, 2018. Dr. Leonard serves as a Director of Biotechnology Innovation Organization. He is a Director of the National Association for Biomedical Research (NABR). Dr. Leonard served as Member of Scientific Advisory Board at Verseon Corporation until 2019. He served as a Director of Vitae Pharmaceuticals, Inc. from July 29, 2015 to October 25, 2016. Dr. Leonard served as a Board Member of a number of organizations including Reata Pharmaceutical. He served as a Director of Arisaph Pharmaceuticals, Inc. since 2007. Dr. Leonard has good career in pharmaceutical R&D, healthcare management, research and development and medicine. He is among the leading R&D executives who have not only introduced breakthrough medicines, but also guided their development into mega-blockbuster drugs. Dr. Leonard is Board certified in Internal Medicine and is licensed to practice in Illinois and Maryland. He completed an Internship and Residency in Internal Medicine at Stanford University Hospital followed by a Postdoctoral Fellowship in Molecular Virology at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Leonard earned an MD from Johns Hopkins University in Baltimore, completed his residency in Internal Medicine at Stanford University followed by a fellowship at the National Institutes of Health and received a BA in Biochemistry at the University of Wisconsin.
Positions
- Company NameIQVIA Holdings Inc.Stock CodeIQVPositionIndependent Lead DirectorColleagues
- ABAri BousbibCEO & Chairman
- EMEric M. SherbetExecutive VP, General Counsel & Secretary
- WRW. Richard StaubPresident of Research & Development Solutions
- AGAlistair GrenfellPresident of Commercial Solutions
- MJMichael J. FedockExecutive VP & Chief Financial Officer
- JAJames A. FasanoIndependent Director
- CAColleen A. GogginsIndependent Director
- CJCarol J. BurtIndependent Director
- JMJohn M. LeonardIndependent Lead Director
- Company NameIntellia Therapeutics, Inc.Stock CodeNTLAPositionPresident, CEO & DirectorColleagues
- FAFranciscus A. G. M. VerwielIndependent Chairman of the Board
- EJEdward J. DulacExecutive VP, CFO & Treasurer
- BSBirgit SchultesExecutive VP & Chief Scientific Officer
- JEJames E. BastaExecutive VP, General Counsel & Corporate Secretary
- RERachel E. HaurwitzCo-Founder
- JAJennifer A. DoudnaFounder & Member of Scientific Advisor Board
- DJDerrick J. RossiFounder & Member of Scientific Advisor Board
- RBRodolphe BarrangouFounder & Member of Scientific Advisor Board
